Items where Research Centre is "Antimicrobial Resistance Centre (AMR)"

Jump to: 2001
Number of items: 12.
2001
Bloland, P;
D'Alessandro, U;
Ringwald, P;
Watkins, W (Technical Advisers: Warhurst, D;
et al);
(2001)
Monitoring antimalarial drug resistance (report of a WHO Consultation).
Technical Report.
WHO, Geneva.
https://researchonline.lshtm.ac.uk/id/eprint/4979
Coast, J;
Smith, R;
(2001)
Antimicrobial resistance: can economics help?
Eurohealth, 7 (2).
pp. 32-33.
ISSN 1356-1030
https://researchonline.lshtm.ac.uk/id/eprint/10130
Full text not available from this repository.
Croft, SL;
(2001)
Monitoring drug resistance in leishmaniasis.
Tropical medicine & international health, 6 (11).
pp. 899-905.
ISSN 1360-2276
DOI: https://doi.org/10.1046/j.1365-3156.2001.00754.x
Full text not available from this repository.
Croft, Simon;
(2001)
Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery.
Drug discovery today, 6 (22).
1151-.
ISSN 1359-6446
DOI: https://doi.org/10.1016/s1359-6446(01)02035-9
Full text not available from this repository.
Goodman, CA;
Coleman, PG;
Mills, AJ;
(2001)
Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs.
Health economics, 10 (8).
pp. 731-749.
ISSN 1057-9230
DOI: https://doi.org/10.1002/hec.621
Full text not available from this repository.
Kelly, JM;
Quack, G;
Miles, MM;
(2001)
In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.
Antimicrobial agents and chemotherapy, 45 (5).
pp. 1360-1366.
ISSN 0066-4804
DOI: https://doi.org/10.1128/AAC.45.5.1360-1366.2001
Full text not available from this repository.
Omar, SA;
Adagu, IS;
Gump, DW;
Ndaru, NP;
Warhurst, DC;
(2001)
Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area.
Annals of tropical medicine and parasitology, 95 (7).
pp. 661-669.
ISSN 0003-4983
DOI: https://doi.org/10.1080/00034980120103234
Full text not available from this repository.
Smith, R;
Coast, J;
Millar, M;
Wilton, P;
Karcher, A.-, M;
(2001)
Interventions against antimicrobial resistance - a review of the literature and exploration of modelling cost effectiveness.
Technical Report.
Global Forum for Health Research, World Health Organisation, Geneva.
https://researchonline.lshtm.ac.uk/id/eprint/10105
Full text not available from this repository.
Warhurst, D;
(2001)
New developments: chloroquine-resistance in Plasmodium falciparum.
Drug resistance updates, 4 (3).
pp. 141-144.
ISSN 1368-7646
DOI: https://doi.org/10.1054/drup.2001.0194
Full text not available from this repository.
Warhurst, DC;
(2001)
A molecular marker for chloroquine-resistant falciparum malaria.
The New England journal of medicine, 344 (4).
pp. 299-302.
ISSN 0028-4793
DOI: https://doi.org/10.1056/NEJM200101253440411
Warhurst, DC;
Adagu, IS;
Beck, HP;
Duraisingh, MT;
Kirby, GC;
von Seidlein, L;
Wright, CW;
(2001)
Mode of action of artemether lumefantrine (COARTEM): The sole, fixed, oral ADCC and its role in combatting multidrug resistance.
The Southeast Asian journal of tropical medicine and public health, 32 (suppl.).
pp. 4-8.
ISSN 0125-1562
https://researchonline.lshtm.ac.uk/id/eprint/1904
Wilton, P;
Smith, RD;
Coast, J;
Millar, M;
Karcher, A;
(2001)
Directly observed treatment for multidrug-resistant tuberculosis: an economic evaluation in the United States of America and South Africa.
The international journal of tuberculosis and lung disease, 5 (12).
pp. 1137-1142.
ISSN 1027-3719
https://researchonline.lshtm.ac.uk/id/eprint/10068
Full text not available from this repository.